Augment Health, Inc. — SEC Form D Filing
Augment Health, Inc. filed an SEC Form D on October 21, 2026, reporting $320K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 21, 2026
- Amount reported
- $320K
- Round stage
- Seed
- Industry
- Medical Devices
- Website
- https://augment.health/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients with bladder dysfunction, such as overactive or neurogenic bladder, lack continuous daily monitoring, while traditional clinical urodynamics suffer from scheduling delays and difficulty replicating real-world symptoms.
Solution
Augment Health develops a smart bladder monitor using a catheter attachment worn for 24 to 48 hours to track ambulatory bladder pressure and transmit real-time data to a clinician dashboard for treatment evaluation.
Why now
Miniaturized biosensors and remote patient monitoring tech now enable real-time organ tracking outside traditional hospital settings.
Verdict
This cleared because investors underwrote an inexpensive, milestone-driven hardware wedge addressing the known clinical failure of episodic urodynamics, not because they believed an invasive catheter attachment could scale into a durable remote patient monitoring platform. The check size reflects a translational grant-extension bet: can continuous ambulatory pressure data deliver superior diagnostic yield? The narrative’s durability was capped by the form factor itself, which confines the addressable population to already-catheterized patients and risks fierce clinician pushback on patient compliance and infection liability.
Source: SEC EDGAR Form D filing